T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects

Journal of Neuroimmunology

Volumn 84, Issue 2, 1998, Pages 172-178

  Trotter, John L ^a   Pelfrey, Clara M ^a   Trotter, Amy L ^a   Selvidge, Jacqueline A ^a   Gushleff, Kelly C ^a   Mohanakumar, T ^a   McFarland, Henry F ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Multiple sclerosis; Myelin proteolipid protein; T cells

Indexed keywords

PROTEOLIPID PROTEIN;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE;

EID: 0032522194     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00260-9     Document Type: Article

References (57)

1. Acha-Orbea H., Mitchell D.J., Timmerman L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T cell receptors from T lymphocytes mediating encephalomyelitis allows specific immune intervention. Cell. 54:1988;263-273.
2. Allegretta M., Nicklas J.A., Sriram S., Albertini R.J. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 247:1990;718-721.
3. Amor S., Baker D., Groome N., Turk J.L. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. J. Immunol. 150:1993;5666-5672.
4. Chou Y.K., Bourdette D.N., Offner H., Whitham R., Wang R.Y., Hashim G.A., Vandenbark A.A. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and CSF in MS. J. Neuroimmunol. 38:1992;105-114.
5. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:1990;162-170.
6. Cross A.H., Tuohy V.K., Raine C.S. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:1993;261-269.
7. Devaux B., Enderlin F., Wallner B., Smilek D.E. Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. J. Neuroimmunol. 75:1997;169-173.
8. Diehl H.J., Schaich M., Budzinski R.M., Stoffel W. Individual exons encode the integral membrane domains of human myelin proteolipid protein. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9807-9811.
9. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
10. Gaur A., Wiers B., Liu A., Rothbard J., Fathman C.G. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science. 258:1992;1491-1494.
11. Greer J.M., Kuchroo V.K., Sobel R.A., Lees M.B. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:1992;783-788.
12. Hampson D.R., Poduslo S.E. Purification of proteolipid protein and production of specific antiserum. J. Neuroimmunol. 11:1986;117-129.
13. Hashim G.A., Vandenbark A., Galang A.B., Diamanduros T., Carvalho E., Srinivasan J., Jones R., Vainiene M., Morrison W.J., Offner H. Antibodies specific for Vβ8 receptor peptide suppress experimental autoimmune encephalomyelitis. J. Immunol. 144:1990;4621-4627.
14. Howell M.D., Winters S.T., Olee T., Powell H.C., Carlo D.J., Brostoff S.W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science. 246:1989;668-670.
15. Johns T.G., Kerlero de Rosbo N., Menon K., Abo S., Gonzales M.F., Bernard C.C.A. Demyelinating encephalomyelitis resembling multiple sclerosis after immunization with a peptide from myelin oligodendrocyte glycoprotein. J. Immunol. 154:1995;5536-5541.
16. Jones R.E., Bourdette D.N., Offner H., Vandenbark A.A. Myelin basic protein-specific T cells induce demyelinating experimental autoimmune encephalomyelitis in Buffalo rats. J. Neuroimmunol. 30:1990;61-69.
17. Kennedy M.K., Tan L.J., DalCanto M.C., Miller S.D. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptide. J. Immunol. 1441:1990;909-915.
18. s molecules. J. Immunol. 145:1990;1687-1693.
19. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
20. Lipham W.J., Redmond T.M., Takahashi H., Berzofsky J.A., Wiggert B., Chader G.J., Gery I. Recognition of peptides that are immunopathogenic but cryptic. J. Immunol. 146:1991;3757-3762.
21. Lisak R.P., Zweiman B., Whitaker J.N. Spinal fluid basic protein immunoreactive material and spinal fluid lymphocyte reactivity to basic protein. Neurology. 31:1981;180-182.
22. Markovic-Plese S., Fukaura H., Zhang J., al-Sabbagh A., Southwood S., Sette A., Kuchroo V.K., Hafler D.A. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155:1995;982-992.
23. Martin R., Jaraquemada D., Flerlage M., Richert J., Brostoff S., Long E.O., McFarlin D.E., McFarland H.F. Fine specificity and HLA restriction of myelin basic protein specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:1990;540-548.
24. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
25. McCarron R.M., Fallis R.J., McFarlin D.E. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:1990;73-79.
26. McFarlin, D.E., McFarland, H.F., 1982. Multiple sclerosis (Review). New. Eng. J. Med. 307, 1183-1188, 1246-1251.
27. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:1995;75-85.
28. Miller S.D., McRae B.L., Vanderlugt C.L., Nikcevich K.M., Pope J.G., Pope L., Karpus W.J. Evolution of the T-cell repertoire during the course of experimental immune mediated demyelinating disease. Immunol. Rev. 144:1995;226-244.
29. Ohashi T., Yamamura T., Inobe J., Kondo T., Kunishita T., Tabira T. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis; identification of PLP 95-116 as an HLA-DR2, w15-associated determinant. Int. Immunol. 7:1995;1771-1778.
30. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
31. Owhashi M., Heber-Katz E. Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors. J. Exp. Med. 168:1988;2153-2163.
32. Pelfrey C.M., Trotter J.L., Tranquill L.R., McFarland H.F. Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from MS patients. J. Neuroimmunol. 46:1993;33-42.
33. Pelfrey C.M., Trotter J.L., Tranquill L.R., McFarland H.F. Identification of a second T cell epitope of human proteolipid protein (Residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J. Neuroimmunol. 53:1994;153-162.
34. Perry L.L., Barzaga M.E. Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis. J. Immunol. 138:1987;1434-1441.
35. Perry L.L., Barzaga E., Trotter J.L. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 33:1991;7-15.
36. Pettinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2-T lymphocytes. J. Immunol. 127:1981;1420-1426.
37. Richert J.R., Robinson E.D., Deibler G.E., Martenson R.E., Dragovic L.J., Kies M.W. Evidence for multiple human T cell recognition sites on myelin basic protein. J. Neuroimmunol. 23:1989;55-66.
38. Sakai K., Zamvil S.S., Mitchell D.J., Hodgkinson S., Rothbard J.B., Steinman L. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Proc. Natl. Acad. Sci. 86:1989;9470-9474.
39. Sercarz E.E., Lehmann P.V., Amentani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:1993;729-766.
40. Sharma S.C., Nag B., Su X.M., Green D., Spack E., Clark B.R., Sriram S. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex - peptide complexes. Proc. Natl. Acad. Sci. 88:1991;11465-11469.
41. Smilek D.E., Wraith D.C., Hodgkinson S., Dwivedy S., Steinman L., McDevitt H.O. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. 88:1991;9633-9637.
42. Sun J.B., Olsson T., Wang W.Z., Xiao B.G., Kostulas V., Fredrikson S., Ekre H.P., Link H. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1991;1461-1468.
43. Trotter J.L., Lieberman L., Margolis F.L., Agrawal H.C. Radioimmunoassay for central nervous system myelin specific proteolipid protein. J. Neurochem. 32:1981;1256-1262.
44. Trotter J.L., Clark H.B., Collins K.G., Wegenscheide C.L., Scarpellini J.D. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79:1987;173-188.
45. Trotter J.L., Hickey W.F., van der Veen R.C., Sulze L. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J. Neuroimmunol. 33:1991;55-62.
46. Trotter J.L., Damico C.A., Cross A.H., Pelfrey C.M., Karr R.W., Fu X., McFarland H.F. HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptides. J. Neuroimmunol. 75:1997;95-103.
47. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., Lees M.B. A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 141:1988;1226-1230.
48. Vandenbark A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region against experimental autoimmune encephalomyelitis. Nature. 341:1989;541-544.
49. Vandenbark A.A., Vainiene M., Celnik B., Hashim G., Offner H. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system. J. Neuroimmunol. 39:1992;251-260.
50. van der Veen R.C., Trotter J.L., Clark H.B., Kapp J.A. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21:1989;183-191.
51. van der Veen R.C., Trotter J.L., Hickey W.F., Kapp J.A. The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein. J. Neuroimmunol. 26:1990;139-145.
52. van der Veen R.C., Trotter J.L., Kapp J.A. Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells. J. Neuroimmunol. 38:1992;139-146.
53. Whitham R.H., Jones R.E., Hashim G.A., Hoy C.M., Wang R.Y., Vandenbark A.A., Offner H. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis. J. Immunol. 147:1991;3803-3808.
54. Wraith D.C., Smilek D.E., Mitchell D.J., Steinman L., McDevitt H.O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:1989;247-255.
55. Yamamura T., Namikawa T., Endoh M., Kunishita T., Tabira T. Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J. Neuroimmunol. 12:1986;143-146.
56. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1996;1777-1788.
57. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.